Literature DB >> 8801206

Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines.

M F Bernet-Camard1, M H Coconnier, S Hudault, A L Servin.   

Abstract

Self protection of host cells against inadvertent injury resulting from attack by autologous complement proteins is well reported for vascular epithelium. In intestinal epithelium, the expression of C complement proteins and regulatory proteins remains currently poorly reported. This study looked at the distribution of C complement proteins and regulatory decay accelerating factor (DAF) in four cultured human intestinal cell lines of embryogenic or colon cancer origins. C3 and C4 proteins and DAF were widely present in human colon adenocarcinoma T84, HT-29 glc-/+ cells compared with human embryonic INT407 cells. In contrast, no expression of C5, C5b-9, and CR1 was seen for any of the cell lines. Taking advantage of the Caco-2 cells, which spontaneously differentiate in culture, it was seen that the C3, C4, and DAF were present in undifferentiated cells and that their expression increased as a function of the cell differentiation. These results, taken together with other reports on the presence of C complement proteins and DAF in the intestinal cells infer that the expression of regulatory C complement proteins develops in parallel with the expression of C proteins to protect these cells against the potential injury resulting from the activation of these local C proteins. Moreover, the finding that the pathogenic C1845 Escherichia coli binds to the membrane bound DAF in the cultured human intestinal cells synthetising locally C proteins and regulatory C proteins supports the hypothesis that E coli could promote inflammatory disorders by blocking local regulatory protein function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801206      PMCID: PMC1383032          DOI: 10.1136/gut.38.2.248

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

Review 1.  The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures.

Authors:  D Louvard; M Kedinger; H P Hauri
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Use of purified F1845 fimbrial adhesin to study localization and expression of receptors for diffusely adhering Escherichia coli during enterocytic differentiation of human colon carcinoma cell lines HT-29 and Caco-2 in culture.

Authors:  S Kerneis; S S Bilge; V Fourel; G Chauviere; M H Coconnier; A L Servin
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549.

Authors:  B L Rothman; A W Despins; D L Kreutzer
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

4.  Structural analysis of a human intestinal epithelial cell line.

Authors:  J L Madara; J Stafford; K Dharmsathaphorn; S Carlson
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

5.  Hydrophobic adhesin of E coli in ulcerative colitis.

Authors:  D A Burke; A T Axon
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

6.  Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation.

Authors:  T Lesuffleur; A Kornowski; C Augeron; E Dussaulx; A Barbat; C Laboisse; A Zweibaum
Journal:  Int J Cancer       Date:  1991-11-11       Impact factor: 7.396

7.  Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease.

Authors:  T S Halstensen; M Hvatum; H Scott; O Fausa; P Brandtzaeg
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

8.  Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose.

Authors:  A Zweibaum; M Pinto; G Chevalier; E Dussaulx; N Triadou; B Lacroix; K Haffen; J L Brun; M Rousset
Journal:  J Cell Physiol       Date:  1985-01       Impact factor: 6.384

9.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

10.  Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.

Authors:  M E Medof; E I Walter; J L Rutgers; D M Knowles; V Nussenzweig
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  21 in total

1.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Pyelonephritogenic diffusely adhering Escherichia coli EC7372 harboring Dr-II adhesin carries classical uropathogenic virulence genes and promotes cell lysis and apoptosis in polarized epithelial caco-2/TC7 cells.

Authors:  J Guignot; J Breard; M F Bernet-Camard; I Peiffer; B J Nowicki; A L Servin; A B Blanc-Potard
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix.

Authors:  Dae Hoon Jeong; Hyoung Kyu Kim; Abd-Ei Bary Prince; Dae Sim Lee; Young Nam Kim; Jin Han; Ki Tae Kim
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

4.  Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).

Authors:  Y M Qian; M Haino; K Kelly; W C Song
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 5.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 6.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

7.  Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells.

Authors:  I Peiffer; A L Servin; M F Bernet-Camard
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Polyunsaturated fatty acid metabolism in enterocyte models: T84 cell line vs. Caco-2 cell line.

Authors:  Pauline Beguin; Anne-Catherine Schneider; Eric Mignolet; Yves-Jacques Schneider; Yvan Larondelle
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-27       Impact factor: 2.416

10.  A structural study of the interaction between the Dr haemagglutinin DraE and derivatives of chloramphenicol.

Authors:  David M Pettigrew; Pietro Roversi; Stephen G Davies; Angela J Russell; Susan M Lea
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.